Antipeptic Drugs Industry News & Blogs

Industry News & Blogs

Covis Pharma to Acquire U S Rights from
www.biospace.com | Dec 22, 2011
ZUG, Switzerland, Dec. 22, 2011 /PRNewswire/ -- Covis Pharma Sarl , a Switzerland-based specialty pharmaceutical company owned by affiliates of

The Sun May Not Rise At Horizon Pharma For Duexis - Seeking Alpha
seekingalpha.com | Dec 18, 2011
< strong > By < a href='http://scriptvolume.blogspot.com/' > ScriptVolume < /a > : < /strong > < p > Horizon Pharma ( < a href='http://seekingalpha.com/symbol/hznp' title='Horizon Pharma' > HZNP < /a > ) recently announced the launch of Duexis, a combination of ibuprofen 800 mg and famotidine 26.6

United States Joins Whistleblower Case Accusing Par Pharmaceuticals of Nationwide Drug Switching
www.prweb.com | Sep 6, 2011
A leading generic drug distributor, Par Pharmaceuticals, and two foreign companies defrauded government healthcare systems through a nationwide drug switching scheme, alleges a whistleblower lawsuit that became public today when it was unsealed by the federal court in Chicago. According to the

Brioschi Now Available at Harris Teeter Stores | PRLog
www.prlog.org | Aug 26, 2011
Brioschi Now Available at Harris Teeter Stores. Brioschi will begin selling their famed antacid brand at all Harris Teeter locations - PR11638365

AstraZeneca's NEXIUM receives first regulatory approval in Japan | Pharma Asia
www.pharmaasia.com | Jul 1, 2011
AstraZeneca announced that NEXIUM (esomeprazole magnesium) 10 mg and 20 mg capsules have received regulatory approval in Japan for the treatment of acid-related conditions including non-erosive reflux disease (NERD), reflux esophagitis, and peptic ulcer disease (PUD). NEXIUM also received

FT.com / Companies / Healthcare - Reckitt faces £89m NHS lawsuit over Gaviscon
www.ft.com | Apr 17, 2011
The consumer goods group said it will 'vigorously defend' itself against claims, after the OFT fined it for abusing its dominant position by withdrawing the drug

Medical News: GI Panel Votes on Ulcers as Endpoints; GERD - in Public Health & Policy, FDA General
www.medpagetoday.com | Nov 5, 2010
GAITHERSBURG, Md. -- The FDA's Gastrointestinal Drugs Advisory Committee took up two issues this week: whether ulcers can serve as an endpoint in trials testing drugs that prevent upper gastrointestin

Misoprostol use in the community to reduce maternal death : The Lancet
www.thelancet.com | Sep 21, 2010
Misoprostol use in the community to reduce maternal death. By - A Metin Gülmezoglu, Matthews Mathai, João Paulo Souza, Catherine d'Arcangues, Michael Mbizvo

Approval of Additional Indications for Helicobacter pylori Eradication by Concomitant Therapy with
www.takeda.com | Jun 18, 2010
Osaka and Tokyo, Japan, June 18, 2010 --- Takeda Pharmaceutical Company Limited (Osaka, President and CEO: Yasuchika Hasegawa), AstraZeneca K.K. (Osaka, President and CEO: Masahiro Kato), Mitsubishi Tanabe Pharma Corporation (Osaka; President and CEO: Michihiro Tsuchiya), and Eisai Co., Ltd.

Proton Pump Inhibitors (PPI): Class Labeling Change
www.fda.gov | May 26, 2010
Possible increased risk of fractures of the hip, wrist, and spine.